August 05, 2015
Kite Pharma to Present at the Canaccord Genuity 35th Annual Growth Conference
SANTA MONICA, Calif., Aug. 5, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (Nasdaq:KITE) today announced that management will present a company overview at the Canaccord Genuity 35th Annual Growth Conference on August 12, 2015 at 1:30pm Eastern Time. The conference will be held in Boston, MA.
The presentation will be available through the Calendar of Events section of Kite's website at ir.kitepharma.com.
About Kite Pharma
Kite Pharma, Inc., is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on engineered autologous T cell therapy (eACT™) designed to restore the immune system's ability to recognize and eradicate tumors. Kite is based in Santa Monica, CA. For more information on Kite Pharma, please visit www.kitepharma.com.
CONTACT: Kite PharmaCynthia M. Butitta
Chief Financial Officer and Chief Operating Officer
310-824-9999
For Media: Justin Jackson
For Investor Inquiries: Lisa Burns and Carol WertherBurns McClellan
212-213-0006
jjackson@burnsmc.com
lburns@burnsmc.com
cwerther@burnsmc.com
Kite Pharma, Inc.
News Provided by Acquire Media
